Enrica Giuffrida - Publications

Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform.

Journal: Scandinavian journal of gastroenterology

Published: September 23, 2022

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.

Journal: Inflammatory bowel diseases

Published: November 26, 2021

Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 05, 2021

From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s.

Journal: World journal of gastrointestinal surgery

Published: February 07, 2021

Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 08, 2021

Effectiveness of Ustekinumab on Crohn's Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Journal: Expert opinion on biological therapy

Published: September 28, 2020

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases.

Journal: International ophthalmology

Published: February 23, 2020

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.

Journal: Inflammatory bowel diseases

Published: December 31, 2019

Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2.

Journal: Alimentary pharmacology & therapeutics

Published: December 28, 2018